Slide 1: Q1 2022 Update
Q1 2022 Update May 2022 Innovation through formulation
Slide 2: Agenda
Agenda 1• Key developments & business update 2• Financial performance 3• Outlook 4• Q&A 2 © 2022 Azelis group. All rights reserved
Slide 3: Disclaimer
Disclaimer This document may contain statement relevant to Azelis Group NV (the “Company”) and/or its affiliated companies (collectively “Azelis” or the “Azelis Group”) which are not historical facts and are hereby identified as “forward-looking statements”. Such forward looking statements, include,
Slide 4: Key developments & business update Q1 2022
Key developments & business update Q1 2022 4 © 2022 Azelis group. All rights reserved
Slide 5: Key developments Q1 2022
Key developments Q1 2022 Strong start to the year Profit improvements Progress on initiatives Balance Sheet • 59.4% total revenue • 71.3% increase in • Continued investments • € 57.9m Free Cashflow growth gross profit in digital strategy reflects impact of elevated working • Record organic growth •
Slide 6: Business update: Strong start to the year
Business update: Strong start to the year Organic growth: 32.6% in Q1 2022 • Strong end-market demand • Life Sciences: F&H recovery and continued positive trends in Personal Care sustain momentum • Industrial chemicals: Continued strength in CASE in the US, M&A: 3 acquisitions in Q1 2022 • Represent
Slide 7: Financial performance Q1 2022
Financial performance Q1 2022 7 © 2022 Azelis group. All rights reserved
Slide 8: Headline P&L Q1 2022
Headline P&L Q1 2022 Azelis Group Highlights Q1 2022 Q1 2021 Reported Change Constant Currency (EUR m) Life Sciences 592.8 372.6 59.1% 57.0% Industrial Chemicals 382.5 239.1 60.0% 56.4% Group Revenue 975.3 611.7 59.4% 56.8% Gross Profit 235.9 137.8 71.3% 68.7% Gross Profit Margin 24.2% 22.5% 167 bp
Slide 9: Headline growth Q1 2022
Headline growth Q1 2022 Azelis Performance F/X M&A Growth Organic Total Q1 2022 Q1 2021 (EUR m) Translation Contribution Growth Growth EMEA 450.5 297.1 -1.8% 19.5% 33.9% 51.6% Americas 366.5 243.7 7.4% 15.1% 27.9% 50.4% Asia Pacific 158.3 70.9 5.3% 74.5% 43.6% 123.4% Group Revenue 975.3 611.7 2.7% 2
Slide 10: Regional financial update
Regional financial update EMEA Americas Asia Pacific 53.9% 53.5% 13.3% 13.6% +51.6% 47.9% +50.4 € 451 49.4% € 367 43.2% 11.5% 10.5% 8.6% € 297 +123.4% € 244 34.2% € 158 7.1% € 71 Q1 2021 Q1 2022 Q1 2021 Q1 2022 Q1 2021 Q1 2022 € Revenue % Adjusted EBITA Margin: Operating profit or loss before amorti
Slide 11: Working Capital
Working Capital Working Capital Evolution of NWC* Receivables Inventory Payables NWC/ 9.2% 10.9% 11.1% 15.3% 10.8% 14.6% Revenue 550 467 276 262 268 256 502 376 282 167 200 218 -247 -227 -235 -294 -369 -467 2018 2019 2020 2021 2021 Q1 2022 Q1 2018 2019 2020 2021 Q1 2021 Q1 2022 Jan Feb Mar Apr May J
Slide 12: Outlook
Outlook 12 © 2022 Azelis group. All rights reserved
Slide 13: Outlook
Outlook Our strategy of driving growth is underpinned by a constantly strengthening lateral value chain, supported by continuous investments in innovation capabilities and digitalization, as well as a commitment to sustainability to create long-term value. In line with this, we are positive that we
Slide 14: Q1 2022 Update Q&A
Q1 2022 Update Q&A Contact Investor Relations investor-relations@azelis.com +32 (0) 478 51 23 89 14 © 2022 Azelis group. All rights reserved